Global Digital Genome Market Information by Disease (cancer, diabetes), by End users hospitals, research laboratories) by application (diagnostics, drug discovery, academic research) - Forecast to 2027
Goldstein Research analyst forecast the digital genome market size is set to reach USD 24.3 billion by 2025, at a CAGR of 8.78% over the forecast years
Genomics is a traditional concept with traces of genome market traced back right from 1926 when a geneticist at the Jackson Laboratory Tom Roderick, coined the term genomics. In 1981, the 1st complete genome sequence of the human mitochondrion (16.6 kb), was registered. Then in 2003 the accomplishment of the Human Genome Project, sequencing of 3.2 billion base pairs of a DNA that make up the human genome, which took many years and cost hefty amounts of time and capital was completely sequenced, with every single human gene sequences were accessible in the public domain.
Get more details @ http://bit.ly/2poGpMf Some of the key companies providing products and services in the digital genome market are Thermo Fisher, Perkin Elmer, Qiagen, Illumina, Becton Dickinson. Agilent, Sigma Aldrich, Fluidigm, Pacific Biosciences, F. Hoffmann-La Roche, Agios, AVEO Oncology and Biomarin, BioReference.
In 2017, the global Digital Health market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2018-2025.
Market Industry Reports (MIR) has published a new report titled “Genome Editing/Genome Engeineering Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019–2030.” According to the report the global genome editing market was valued at over US$ 3.0 Bn. in 2017 and is expected to grow at a double digit CAGR during the forecasted period. The growth of this market can be attributed to the major factor that is utilization of the technique for therapeutic genetic editing in infected tissues and cells, thereby reducing the mutations.
Get more details @ http://bit.ly/2nUpHlT Some of the key companies providing products and services in the digital genome market are Thermo Fisher, Perkin Elmer, Qiagen, Illumina, Becton Dickinson. Agilent, Sigma Aldrich, Fluidigm, Pacific Biosciences, F. Hoffmann-La Roche, Agios, AVEO Oncology and Biomarin, BioReference.
Get more details @ http://bit.ly/2nUpHlT Some of the key companies providing products and services in the digital genome market are Thermo Fisher, Perkin Elmer, Qiagen, Illumina, Becton Dickinson. Agilent, Sigma Aldrich, Fluidigm, Pacific Biosciences, F. Hoffmann-La Roche, Agios, AVEO Oncology and Biomarin, BioReference.
The global digital biomanufacturing market report highlights that the market was valued at $15,768.9 million in 2021 and is expected to reach $55,564.9 million by the end of 2031. The market is expected to grow at a CAGR of 13.12% during the forecast period from 2022 to 2031.
The spatial genomics and transcriptomics market was estimated at $269.6 Million in 2020 and is expected to grow at a CAGR of 23.20% during the forecast period from 2020-2030.
According to the latest research report by IMARC Group, The global digital PCR market size reached US$ 4.7 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 10.7 Billion by 2032, exhibiting a growth rate (CAGR) of 9.25% during 2024-2032. More Info:- https://www.imarcgroup.com/digital-pcr-market
Single User License: US $2500; Buy the Report @ http://www.sandlerresearch.org/purchase?rname=44172 Alternatively can get Discount on the Report @ http://www.sandlerresearch.org/discount?rname=44172
The global multiplex assays market is expected to register a CAGR of 8.12% during 2024-2032 and reach a revenue of $7793.26 million by 2032. Get more insights
According to the latest research report by IMARC Group, The United States digital PCR market size reached US$ 1.2 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 7.0 Billion by 2032, exhibiting a growth rate (CAGR) of 22.20% during 2024-2032. More Info:- https://www.imarcgroup.com/united-states-digital-pcr-market
Market Overview: Cancer Tissue Diagnostics Market Cancer tissue diagnostics play a pivotal role in oncology by facilitating accurate diagnosis, prognosis, and treatment selection based on tissue samples obtained from patients. The global cancer tissue diagnostics market is witnessing steady growth, driven by the increasing incidence of cancer, advancements in diagnostic technologies, and growing emphasis on personalized medicine.
"AI in Social Media market" In the genomics industry, highlighting higher level geographies and breaking down significant business sectors allows for in-depth study of market data. The study strikes the ideal balance between qualitative and quantitative data about the global market for AI in Social Media market.
The global biomaterials market is anticipated to growing at a CAGR of 12.78%, and is anticipated to reach $269.55 billion by 2030. Get a Free Sample Report.
Bharat Book Bureau Provides the Trending Market Research Report; on “Global Liquid Biopsy Market Forecast 2022”, (https://www.bharatbook.com/diagnostics-market-research-reports-216402/liquid-biopsy-research-tools-services-diagnostics-global.html)The report provides a comprehensive discussion of liquid diagnostic assay technologies, clinical applications, business structure, liquid diagnostic assay funding initiatives, world markets, patent standing and firms.
The Digital PCR (dPCR) and Real-time PCR (qPCR) Market size was estimated at $4876 million in 2020, and is projected to grow at a CAGR of 9.2% during the forecast period 2021-2026.
On the basis of type of application, the global digital PCR and qPCR market is classified into research applications, clinical applications, and forensic applications
Bharat Book Bureau provides the report; on “Liquid Biopsy Research Tools, Services and Diagnostics Global Markets” This report global market is analyzed by application, biomarker type, analysis platform, analysis purpose and geographic region. https://www.bharatbook.com/diagnostics-market-research-reports-216402/liquid-biopsy-research-tools-services-diagnostics.html
Get Sample Brochure of Report @ http://www.marketintelreports.com/pdfdownload.php?id=9dime5731 The report includes detailed analysis on Digital PCR Devices market segmentation, global notable vendors, geographical outlook, price & financial updates, segment & application approach and future forecasts.
This report studies the global digital PCR (dPCR) and qPCR market over the forecast period of 2014 to 2019. The market is expected to reach $3.97 billion by 2019, at CAGR of 7.8% from 2014 to 2019.
Global Molecular Diagnostics Market is anticipated to cross USD 22 Billion by the end of year 2025. Global Forecast by Application, Technology, End User, Regions, Companies. Call Us : +1 678-302-0700 Follow the Link for More Information: https://www.renub.com/molecular-diagnostics-market-nd.php
The global qPCR and dPCR market is expected to reach USD 4.94 Billion by 2021 from USD 3.28 Billion in 2016, growing at a CAGR of 8.5% from 2016 to 2021.
... from industrial plants and automobiles (including airplanes) (Control techniques, ... Efficient ways to generate and distribute energy (electrical distribution) ...
Digital health is the convergence of digital and genomic technologies with health, healthcare, living, and society to enhance the efficiency of healthcare delivery and make medicines more personalized and precise. The discipline involves the use of information and communication technologies to help address the health problems and challenges faced by patients
The market for Epigenetics was valued at a staggering 800 US$ millions in the year 2017 and was expected to grow at a double-digit CAGR in the forecast period of 2019 to the year 2030.
iGATE RESEARCH report titled "Global - Non-Invasive Prenatal Testing (NIPT) Market and Volume Analysis to 2020" is a 107 page report with 40 Figures and 13 Tables. This report analyses the Global - Non-Invasive Prenatal Testing (NIPT) Market and Volume - Top 10 NIPT Test, Major Chromosomal Aneuploidies and their Incidence Rate, Major Deals in the NIPT landscape, NIPT Implementation in HICs and LMICs, Driving factors and Challenges for NIPT market.
Cancer biomarkers are biological molecules that indicate the existence of cancer in a patient. They are formed either by the cancer cells or by noncancer cells in response to cancer.
The Global Precision Oncology market research report provides an insightful analysis of the current market, along with a futuristic perspective on the growth of the market.
Global single-cell analysis market is set to witness a healthy CAGR of 17.5% in the forecast period of 2019 to 2026. The report contains data of the base year 2018 and historic year 2017. This rise in the market can be attributed due to increasing adoption of single-cell analysis for diagnostic.
The global qPCR and dPCR market is expected to reach USD 4.94 billion by 2021 from USD 3.28 billion in 2016, growing at a CAGR of 8.5% during the forecast period. Market growth can be attributed to the rising incidences of infectious diseases and genetic disorders (coupled with growing geriatric population that is at greater risk of target diseases as compared to adults); technological advancements; increasing public-private investments, funds, and grants; successful completion of the Human Genome Project, and rise in the number of hospitals and diagnostic centers.
Non-invasive prenatal testing (NIPT), is a method of determining the risk of whether the fetus of the mother will be born with specific genetic disorders. NIPT is a safe and extremely effective way of screening for conditions such as Down syndrome, Edwards syndrome, Patau syndrome, monosomy X, and Turner syndrome.
The platform centric segment and hybrid models pose significant growth opportunities for the HIE market. The global HIE market is valued at an estimated $558million in 2013 and is expected to grow at a CAGR of 9.5% in the next five years. The global HIE systems market is mainly categorized by set-up type, vendor, implementation model, and by application.
Market Research Future one of the supreme brands in market research industry has published research report on “Gel Documentation Market-Global Forecast to 2023”. Research provides analysis on market size, share, segmentation with top companies’ data.
This study offers a comprehensive, 360 degree analysis on the Neurological Biomarkers market, bringing to fore insights that can help stakeholders identify the opportunities as well as challenges.
Renub Research has announced the addition of the "http://www.renub.com/global-prostate-cancer-therapeutics-market-to-2020-487-p.php" report to its offering
The global digital biomanufacturing market is expected to reach $55,564.9 million by the end of 2031. The market is expected to grow at a CAGR of 13.12% during the forecast period from 2022 to 2031.
Our healthcare experts have found The capillary electrophoresis market to be one of the stable markets, and the global market is predicted to grow at a CAGR of 5.66% during the forecast period 2021-2031.
The global gene cloning services market was valued at $1,983.6 million in 2020 and is expected to reach $11,524.4 million by 2031, growing at a CAGR of 17.29% during the forecast period 2021-2031.
The lung cancer genomic testing medicine market was valued at $1,262.0 million in 2020 and is expected to reach $3,279.8 million by 2031, growing at a CAGR of 8.97% during the forecast period 2021-2031.
The global precision medicine market is expected to reach $278.61 billion by the end of 2030. The market is projected to grow at a CAGR of 11.13% during the forecast period, 2020-2030. Factors driving the growth of the market including advancement of sequencing technologies, rising prevalence of chronic diseases, growing demand for preventive care, and shifting the significance in medicine from reaction to prevention.
According to #TechSci Research report, Global Precision Medicine Market, was valued USD66.85 billion in 2020 and is expected to reach USD125.67 billion, growing at CAGR of 10.65% during the forecast period. Gain More Insight: https://bit.ly/3Df5kr2 Get Sample Report: https://bit.ly/3kneqJG Website: https://www.techsciresearch.com/ Market Research News: https://techsciblog.com/
According to #TechSci Research report, Global Neoantigen Cancer Vaccine Market is projected to grow with a CAGR of 54.18% during the forecast period and is expected to reach USD1754.44 million by 2026. Gain More Insight: https://bit.ly/3DNPxA2 Get Sample Report: https://bit.ly/3DCB0H4 Website: https://www.techsciresearch.com/ Market Research News: https://techsciblog.com/
Market Report Titled "Active Pharmaceutical Ingredients Market Research Report – Forecast to 2023" is a Specialist Examination Report Explores the Market by Research Methodology, Segmentation, Key Players, and Major Region Globally .
The Market Report “Global Assisted Reproductive Technology Market 2018” Offers Vital Insights on every Industry segment in terms of market size analysis for Industry across the different regions.